Maria Grazia Aprea, Irene Schiavetti, Emilio Portaccio, Chiara Ballerini, Simona Bonavita, Maria Buscarinu, Massimiliano Calabrese, Paola Cavalla, Maria Cellerino, Cinzia Cordioli, Vincenzo Dattola, Stefano De Biase, Ermelinda De Meo, Roberta Fantozzi, Antonio Gallo, Luigi Iasevoli, Rana Karabudak, Doriana Landi, Lorena Lorefice, Lucia Moiola, Paolo Ragonese, Francesca Ruscica, Sedat Sen, Leonardo Sinisi, Elisabetta Signoriello, Simona Toscano, Elena Verrengia, Aksel Siva, Camilla Masciulli, Maria Pia Sormani, Maria Pia Amato
BACKGROUND: In the general population, maternal COVID-19 is associated with worse maternal and fetal outcomes. Two previous studies have assessed COVID-19 clinical outcomes in pregnant women with multiple sclerosis (MS), but there are no data about maternal and fetal outcomes. OBJECTIVES: In this multicenter study, we aimed to assess maternal and fetal outcomes in pregnant women with MS and COVID-19 infection. METHODS: We recruited pregnant patients with MS who contracted COVID-19 and were followed up in Italian and Turkish Centers, during 2020-2022...
March 8, 2024: Multiple Sclerosis: Clinical and Laboratory Research